Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 4
2015 4
2016 1
2017 2
2018 6
2019 1
2020 5
2021 7
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
Högnäsbacka AA, Poot AJ, Plisson C, Bergare J, Bonsall DR, McCluskey SP, Wells LA, Kooijman E, Schuit RC, Verlaan M, Beaino W, van Dongen GAMS, Vugts DJ, Elmore CS, Passchier J, Windhorst AD. Högnäsbacka AA, et al. Among authors: beaino w. EJNMMI Res. 2024 Feb 16;14(1):19. doi: 10.1186/s13550-024-01078-6. EJNMMI Res. 2024. PMID: 38363422 Free PMC article.
Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase.
Högnäsbacka AA, Poot AJ, Kooijman E, Schuit RC, Schreurs M, Verlaan M, Beaino W, van Dongen GAMS, Vugts DJ, Windhorst AD. Högnäsbacka AA, et al. Among authors: beaino w. J Med Chem. 2023 Sep 14;66(17):12130-12140. doi: 10.1021/acs.jmedchem.3c00722. Epub 2023 Aug 30. J Med Chem. 2023. PMID: 37647220 Free PMC article.
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor.
Högnäsbacka A, Poot AJ, Kooijman E, Schuit RC, Schreurs M, Verlaan M, van den Hoek J, Heideman DAM, Beaino W, van Dongen GAMS, Vugts DJ, Windhorst AD. Högnäsbacka A, et al. Among authors: beaino w. Nucl Med Biol. 2023 May-Jun;120-121:108349. doi: 10.1016/j.nucmedbio.2023.108349. Epub 2023 May 4. Nucl Med Biol. 2023. PMID: 37209556 Free article.
Imaging the TGFβ type I receptor in pulmonary arterial hypertension.
Rotteveel L, Poot AJ, Kooijman EJM, Schuit RC, Schalij I, Sun X, Kurakula K, Happé C, Beaino W, Ten Dijke P, Lammertsma AA, Bogaard HJ, Windhorst AD. Rotteveel L, et al. Among authors: beaino w. EJNMMI Res. 2023 Mar 22;13(1):23. doi: 10.1186/s13550-023-00966-7. EJNMMI Res. 2023. PMID: 36947258 Free PMC article.
Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essential.
Wuensche TE, Stergiou N, Mes I, Verlaan M, Schreurs M, Kooijman EJM, Janssen B, Windhorst AD, Jensen A, Asuni AA, Bang-Andersen B, Beaino W, Dongen GAMS, Vugts DJ. Wuensche TE, et al. Among authors: beaino w. Theranostics. 2022 Oct 9;12(16):7067-7079. doi: 10.7150/thno.73509. eCollection 2022. Theranostics. 2022. PMID: 36276653 Free PMC article.
Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5.
Rotteveel L, Kurakula K, Kooijman EJM, Schuit RC, Verlaan M, Schreurs M, Beaino W, van Dinther MAH, Ten Dijke P, Lammertsma AA, Poot AJ, Bogaard HJ, Windhorst AD. Rotteveel L, et al. Among authors: beaino w. Nucl Med Biol. 2022 Sep-Oct;112-113:9-19. doi: 10.1016/j.nucmedbio.2022.05.003. Epub 2022 May 24. Nucl Med Biol. 2022. PMID: 35660796 Free article.
39 results